Published online before print June 7, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
,
*Division of Infectious Diseases, Department of Research, University Hospitals, Basel, Switzerland;
Department of Neurosurgery, University Hospital, Zurich, Switzerland;
Departments of Medicine and Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles; and
Laboratory of Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science, Japan
@ To whom correspondence should be addressed. E-mail: Regine.Landmann{at}unibas.ch.
CD14 is a myeloid receptor for bacterial cell membrane/wall components, for which we previously showed a strong induction in cerebrospinal fluid (CSF) during meningitis. Here, we studied CD14 function in murine Streptococcus pneumoniae meningitis by using wild-type (WT), CD14-/- mice, and WT mice pretreated with neutralizing anti-CD14 antibodies. Early polymorphonuclear leukocytes (PMN) immigration was more pronounced in CSF of CD14-/- than of WT mice. This was not a result of altered adherence molecule expression in blood and CSF PMN or brain endothelial cells. Macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine levels were similar in CSF in both strains, but MIP-2 was higher in infected brain and in brain-derived endothelial cells infected in vitro in CD14-/- than in WT mice. CD14-/- PMN demonstrated increased expression of CXC chemokine receptor 2 (CXCR2) after infection and stronger in vitro chemotaxis than WT PMN toward CSF from WT or CD14-/- mice and toward MIP-2. Excess PMN migration in CD14-/- mice did not result in improved bacterial clearing but in increased tumor necrosis factor in CSF, higher disease severity, and earlier death. Pretreatment with anti-CXCR2 reduced PMN infiltration into CSF and brain MIP-2 production and abolished earlier mortality in CD14-/- mice. In conclusion, CD14 has a protective effect in pneumococcal meningitis by slowing PMN migration via MIP-2 and CXCR2 modulation.
Key Words: chemokines polymorphonuclear cells meningitis
This article has been cited by other articles:
![]() |
S. Ribes, S. Ebert, T. Regen, A. Agarwal, S. C. Tauber, D. Czesnik, A. Spreer, S. Bunkowski, H. Eiffert, U.-K. Hanisch, et al. Toll-Like Receptor Stimulation Enhances Phagocytosis and Intracellular Killing of Nonencapsulated and Encapsulated Streptococcus pneumoniae by Murine Microglia Infect. Immun., February 1, 2010; 78(2): 865 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmaler, N. J. Jann, F. Ferracin, L. Z. Landolt, L. Biswas, F. Gotz, and R. Landmann Lipoproteins in Staphylococcus aureus Mediate Inflammation by TLR2 and Iron-Dependent Growth In Vivo J. Immunol., June 1, 2009; 182(11): 7110 - 7118. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Farooq, R. Stillie, M. Svensson, C. Svanborg, R. M. Strieter, and A. W. Stadnyk Therapeutic Effect of Blocking CXCR2 on Neutrophil Recruitment and Dextran Sodium Sulfate-Induced Colitis J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 123 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mildner, M. Djukic, D. Garbe, A. Wellmer, W. A. Kuziel, M. Mack, R. Nau, and M. Prinz Ly-6G+CCR2- Myeloid Cells Rather Than Ly-6ChighCCR2+ Monocytes Are Required for the Control of Bacterial Infection in the Central Nervous System J. Immunol., August 15, 2008; 181(4): 2713 - 2722. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kesteman, G. Vansanten, B. Pajak, S. M. Goyert, and M. Moser Injection of lipopolysaccharide induces the migration of splenic neutrophils to the T cell area of the white pulp: role of CD14 and CXC chemokines J. Leukoc. Biol., March 1, 2008; 83(3): 640 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Dessing, S. Knapp, S. Florquin, A. F. de Vos, and T. van der Poll CD14 Facilitates Invasive Respiratory Tract Infection by Streptococcus pneumoniae Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Paterson and T. J. Mitchell Innate immunity and the pneumococcus Microbiology, February 1, 2006; 152(2): 285 - 293. [Abstract] [Full Text] [PDF] |
||||